Publications by authors named "Hideki Tomimoto"

Claim this Profile
I
Investigation of the outpatient chemotherapy for lung cancer patients in Tokushima University Hospital.
Hisatsugu Goto, Masaki Hanibuchi, Satoshi Sakaguchi, Takanori Kanematsu, Soji Kakiuchi, Hideki Tomimoto

J Med Invest· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancer.
Hideki Tomimoto, Masaki Hanibuchi, Fumitaka Ogushi, Yoshio Okano, Tsutomu Shinohara

Oncol Lett· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological and clinical features of lung cancer patients from 1999 to 2009 in Tokushima Prefecture of Japan.
Takanori Kanematsu, Masaki Hanibuchi, Hideki Tomimoto, Shoji Sakiyakma, Koichiro Kenzaki

J Med Invest· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Clinical analysis of elderly patients with primary lung cancer].
Koichiro Kenzaki, Shoji Sakiyama, Hideki Tomimoto, Hiroaki Toba, Yasushi Nakagawa

Kyobu Geka· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Differences in the therapeutic strategies for lung cancer between Europe/United States and Japan].
Masaki Hanibuchi, Seiji Yano, Hideki Tomimoto, Saburo Sone

Gan To Kagaku Ryoho· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusions.
Hideki Tomimoto, Seiji Yano, Hiroaki Muguruma, Soji Kakiuchi, Saburo Sone

J Med Invest· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor vascular strategy for controlling experimental metastatic spread of human small-cell lung cancer cells with ZD6474 in natural killer cell-depleted severe combined immunodeficient mice.
Seiji Yano, Hiroaki Muguruma, Yuka Matsumori, Hisatsugu Goto, Emiko Nakataki, Hideki Tomimoto

Clin Cancer Res· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retreatment of lung adenocarcinoma patients with gefitinib who had experienced favorable results from their initial treatment with this selective epidermal growth factor receptor inhibitor: a report of three cases.
Seiji Yano, Emiko Nakataki, Shinsaku Ohtsuka, Mami Inayama, Hideki Tomimoto

Oncol Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis